Paraspinal Muscle Remodeling
1 other identifier
interventional
30
1 country
1
Brief Summary
Lumbar disc herniation is the most common diagnosed degenerative pathology in the lumbar spine with a prevalence of 2 to 3% in the adult population. Unilateral lumbar disc herniation is characterized by compression or irritation of the lumbar nerve roots or dural sac by either protrusion, extrusion or sequestration of the nucleus pulposus, mostly in the posterolateral region. Compression or irritation of the lumbar nerve roots and dural sac can induce unilateral sensory and motor symptoms. Therefore, it is the principal cause of lumbar spinal surgery. Different imaging studies have investigated asymmetry of the paraspinal muscles in patient with unilateral low back pain due to lumbar discus herniation. Both animal and human studies indicate a reduction in total muscle cross-sectional area, increased fat infiltration and fibrosis within the lumbar multifidus at the affected side. Increased fat infiltration is clinically important because there is a correlation between the amount of intramuscular fat and lumbar muscle dysfunction. Not only fat infiltration correlates with lumbar dysfunction, also a lower multifidus cross-sectional area is associated with and predictive for low back pain. This indicates that there is an association between paraspinal muscle changes/ remodeling and muscle dysfunction that could lead to low back pain. The aim of this research is to quantify the decrease in muscle and muscle fibre size, the amount of fat infiltration, and the amount of fibrosis present within the multifidus muscle at the herniated side in relation to the unaffected side. The second aim is to investigate the possible role of different cell types in the process of muscle remodeling. The last aim of this study is to correlate these muscular changes with long-term functional outcomes such as pain, fear and disability. This information can possibly contribute to the etiology of paraspinal muscle changes, and provide a handgrip to future research.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2018
CompletedFirst Submitted
Initial submission to the registry
November 22, 2018
CompletedFirst Posted
Study publicly available on registry
November 27, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2021
CompletedMay 19, 2022
May 1, 2022
3.2 years
November 22, 2018
May 18, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
muscle biopsy sample (musculus multifidus)
Histochemical analyses: Masson's trichrome and haematoxylin and eosin staining will be used to visualize connective and adipose tissues within a muscle cross-section.
day 1
muscle biopsy sample (musculus multifidus)
Immunofluorescent analyses: Primary and secondary immunofluorescent antibody's against MHC I, IIA and IIX, laminin, satellite cells / muscle stem cells (PAX-7, MyoD, Myogenin), fibro-adipogenic cells/ mesenchymal progenitor cells (PDGFR-alfa) and myonuclei (DAPI) will be used.
day 1
muscle biopsy sample (musculus multifidus)
Real-time PCR: Inflammatory markers and growth factors will be measured using real-time polymerase chain reaction.
day 1
MRI
Medical imaging: Pre-operative MRI images will be requested from the department of radiology to measure total muscle cross-sectional area and intramuscular fat infiltration.
day 1
Secondary Outcomes (9)
Numeric Pain Rating Score (NPRS)
day 1
Numeric Pain Rating Score (NPRS)
week 6
Numeric Pain Rating Score (NPRS)
month 6
Modified Oswestry Disability Index (ODI)
day1
Modified Oswestry Disability Index (ODI)
week 6
- +4 more secondary outcomes
Study Arms (1)
LDH (lumbar disc hernia)
EXPERIMENTALInterventions
Bilateral biopsy of the multifidus muscle in patient with a unilateral disc hernia.
Eligibility Criteria
You may qualify if:
- Unilateral lumbar disc hernia (diagnosed using MRI)
- Age between 18-55
- Understanding the Dutch language
You may not qualify if:
- Spinal surgery within the last year
- Degenerative or other spinal pathology (except disc hernia)
- Contraindications to undergo a MRI
- Other known pathologies that might affect muscle biology/ morphology
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hasselt Universitylead
- Ziekenhuis Oost-Limburgcollaborator
- Jessa Hospitalcollaborator
Study Sites (1)
Jessa Ziekenhuis
Hasselt, 3500, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Frank Vandenabeele, prof. dr.
Hasselt University
- STUDY CHAIR
Sjoerd Stevens, drs.
Hasselt University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 22, 2018
First Posted
November 27, 2018
Study Start
July 1, 2018
Primary Completion
August 31, 2021
Study Completion
August 31, 2021
Last Updated
May 19, 2022
Record last verified: 2022-05